Literature DB >> 16876451

Metabolic control during exercise with and without medium-chain triglycerides (MCT) in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency.

Melanie B Gillingham1, Bradley Scott, Diane Elliott, Cary O Harding.   

Abstract

Exercise induced rhabdomyolysis is a complication of long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein (TFP) deficiency that frequently leads to exercise avoidance. Dietary therapy for most subjects includes medium-chain triglyceride (MCT) supplementation but analysis of diet records indicates that the majority of patients consume oral MCT only with breakfast and at bedtime. We hypothesized that MCT immediately prior to exercise would provide an alternative fuel source during that bout of exercise and improve exercise tolerance in children with LCHAD deficiency. Nine subjects completed two 45 min moderate intensity (60-70% predicted maximum heart rate (HR)) treadmill exercise tests. Subjects were given 4 oz of orange juice alone or orange juice and 0.5 g MCT per kg lean body mass, 20 min prior to exercise in a randomized cross-over design. ECG and respiratory gas exchange including respiratory quotient (RQ) were monitored. Blood levels of acylcarnitines, creatine kinase, lactate, and beta-hydroxybutyrate were measured prior to and immediately after exercise, and again following 20 min rest. Creatine kinase and lactate levels did not change with exercise. There was no significant difference in RQ between the two exercise tests but there was a decrease in steady-state HR following MCT supplementation. Cumulative long-chain 3-hydroxyacylcarnitines were 30% lower and beta-hydroxybutyrate was three-fold higher after the MCT-pretreated exercise test compared to the test with orange juice alone. Coordinating MCT supplementation with periods of increased activity may improve the metabolic control of children with LCHAD and TFP deficiency following exercise.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876451      PMCID: PMC2706834          DOI: 10.1016/j.ymgme.2006.06.004

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  17 in total

1.  Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders.

Authors:  J J Shen; D Matern; D S Millington; S Hillman; M D Feezor; M J Bennett; M Qumsiyeh; S G Kahler; Y T Chen; J L Van Hove
Journal:  J Inherit Metab Dis       Date:  2000-02       Impact factor: 4.982

2.  Comparison of peak performance measures in children ages 6 to 8, 9 to 10, and 11 to 13 years.

Authors:  T B Gilliam; S Sady; W G Thorland; A L Weltman
Journal:  Res Q       Date:  1977-12

3.  Effect of optimal dietary therapy upon visual function in children with long-chain 3-hydroxyacyl CoA dehydrogenase and trifunctional protein deficiency.

Authors:  Melanie B Gillingham; Richard G Weleber; Martha Neuringer; William E Connor; Monte Mills; Sandy van Calcar; James Ver Hoeve; Jon Wolff; Cary O Harding
Journal:  Mol Genet Metab       Date:  2005-07-22       Impact factor: 4.797

4.  Effect of physical training on hemodynamic response during submaximal and maximal exercise in 11-13-year old boys.

Authors:  B O Eriksson; G Koch
Journal:  Acta Physiol Scand       Date:  1973-01

5.  Cardio-respiratory response to treadmill exercise in normal children.

Authors:  S D Anderson; S Godfrey
Journal:  Clin Sci       Date:  1971-05       Impact factor: 6.124

6.  Cardio-respiratory response to exercise in normal children.

Authors:  S Godfrey; C T Davies; E Wozniak; C A Barnes
Journal:  Clin Sci       Date:  1971-05       Impact factor: 6.124

7.  Utilization of medium-chain triglycerides by neonatal piglets: II. Effects of even- and odd-chain triglyceride consumption over the first 2 days of life on blood metabolites and urinary nitrogen excretion.

Authors:  J Odle; N J Benevenga; T D Crenshaw
Journal:  J Anim Sci       Date:  1989-12       Impact factor: 3.159

8.  Utilization of medium-chain triglycerides by neonatal piglets: chain length of even- and odd-carbon fatty acids and apparent digestion/absorption and hepatic metabolism.

Authors:  J Odle; N J Benevenga; T D Crenshaw
Journal:  J Nutr       Date:  1991-05       Impact factor: 4.798

9.  Molecular and phenotypic heterogeneity in mitochondrial trifunctional protein deficiency due to beta-subunit mutations.

Authors:  Ute Spiekerkoetter; Bin Sun; Zaza Khuchua; Michael J Bennett; Arnold W Strauss
Journal:  Hum Mutat       Date:  2003-06       Impact factor: 4.878

10.  Optimal dietary therapy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

Authors:  Melanie B Gillingham; William E Connor; Dietrich Matern; Piero Rinaldo; Terry Burlingame; Kaatje Meeuws; Cary O Harding
Journal:  Mol Genet Metab       Date:  2003-06       Impact factor: 4.797

View more
  25 in total

1.  Variability in the clinical management of fatty acid oxidation disorders: results of a survey of Canadian metabolic physicians.

Authors:  Beth K Potter; Julian Little; Pranesh Chakraborty; Jonathan B Kronick; Jessica Evans; Julia Frei; Sarah C Sutherland; Kumanan Wilson; Brenda J Wilson
Journal:  J Inherit Metab Dis       Date:  2011-06-01       Impact factor: 4.982

Review 2.  Mitochondrial fatty acid oxidation disorders: pathophysiological studies in mouse models.

Authors:  Ute Spiekerkoetter; Philip A Wood
Journal:  J Inherit Metab Dis       Date:  2010-06-08       Impact factor: 4.982

3.  Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop.

Authors:  U Spiekerkoetter; M Lindner; R Santer; M Grotzke; M R Baumgartner; H Boehles; A Das; C Haase; J B Hennermann; D Karall; H de Klerk; I Knerr; H G Koch; B Plecko; W Röschinger; K O Schwab; D Scheible; F A Wijburg; J Zschocke; E Mayatepek; U Wendel
Journal:  J Inherit Metab Dis       Date:  2009-04-28       Impact factor: 4.982

Review 4.  Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency.

Authors:  Kenji Yamada; Takeshi Taketani
Journal:  J Hum Genet       Date:  2018-11-06       Impact factor: 3.172

5.  TAT opens the door.

Authors:  Piyush M Vyas; Ronald M Payne
Journal:  Mol Ther       Date:  2008-04       Impact factor: 11.454

6.  Cardiomyopathy of Friedreich's ataxia: use of mouse models to understand human disease and guide therapeutic development.

Authors:  R Mark Payne; P Melanie Pride; Clifford M Babbey
Journal:  Pediatr Cardiol       Date:  2011-03-01       Impact factor: 1.655

7.  Pre-exercise medium-chain triglyceride application prevents acylcarnitine accumulation in skeletal muscle from very-long-chain acyl-CoA-dehydrogenase-deficient mice.

Authors:  Sonja Primassin; Sara Tucci; Diran Herebian; Annette Seibt; Lars Hoffmann; Frank ter Veld; Ute Spiekerkoetter
Journal:  J Inherit Metab Dis       Date:  2010-05-06       Impact factor: 4.982

8.  Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation.

Authors:  Annie M Behrend; Cary O Harding; James D Shoemaker; Dietrich Matern; David J Sahn; Diane L Elliot; Melanie B Gillingham
Journal:  Mol Genet Metab       Date:  2011-10-01       Impact factor: 4.797

Review 9.  Inborn errors of energy metabolism associated with myopathies.

Authors:  Anibh M Das; Ulrike Steuerwald; Sabine Illsinger
Journal:  J Biomed Biotechnol       Date:  2010-05-26

10.  Sports in LCHAD Deficiency: Maximal Incremental and Endurance Exercise Tests in a 13-Year-Old Patient with Long-Chain 3-Hydroxy Acyl-CoA Dehydrogenase Deficiency (LCHADD) and Heptanoate Treatment.

Authors:  D Karall; G Mair; U Albrecht; K Niedermayr; T Karall; W Schobersberger; S Scholl-Bürgi
Journal:  JIMD Rep       Date:  2014-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.